681 related articles for article (PubMed ID: 20101720)
21. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.
Götz J; Schild A; Hoerndli F; Pennanen L
Int J Dev Neurosci; 2004 Nov; 22(7):453-65. PubMed ID: 15465275
[TBL] [Abstract][Full Text] [Related]
22. Pathological substrates of cognitive decline in Alzheimer's disease.
Giannakopoulos P; Gold G; von Gunten A; Hof PR; Bouras C
Front Neurol Neurosci; 2009; 24():20-29. PubMed ID: 19182459
[TBL] [Abstract][Full Text] [Related]
23. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].
Tamaoka A
Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113
[TBL] [Abstract][Full Text] [Related]
24. Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer's disease.
Nicoll JAR; Buckland GR; Harrison CH; Page A; Harris S; Love S; Neal JW; Holmes C; Boche D
Brain; 2019 Jul; 142(7):2113-2126. PubMed ID: 31157360
[TBL] [Abstract][Full Text] [Related]
25. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
[TBL] [Abstract][Full Text] [Related]
26. Neuropathological diagnosis of Alzheimer's disease: a perspective from longitudinal clinicopathological studies.
Dickson DW
Neurobiol Aging; 1997; 18(4 Suppl):S21-6. PubMed ID: 9330981
[TBL] [Abstract][Full Text] [Related]
27. The biological significance of neuropathological lesions in Alzheimer's disease.
Mori H
Neurobiol Aging; 1997; 18(4):379-82; discussion 389-92. PubMed ID: 9330966
[No Abstract] [Full Text] [Related]
28. Distinct cytokine profiles in human brains resilient to Alzheimer's pathology.
Barroeta-Espar I; Weinstock LD; Perez-Nievas BG; Meltzer AC; Siao Tick Chong M; Amaral AC; Murray ME; Moulder KL; Morris JC; Cairns NJ; Parisi JE; Lowe VJ; Petersen RC; Kofler J; Ikonomovic MD; López O; Klunk WE; Mayeux RP; Frosch MP; Wood LB; Gomez-Isla T
Neurobiol Dis; 2019 Jan; 121():327-337. PubMed ID: 30336198
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical investigation of the brain of aged dogs. I. Detection of neurofibrillary tangles and of 4-hydroxynonenal protein, an oxidative damage product, in senile plaques.
Papaioannou N; Tooten PC; van Ederen AM; Bohl JR; Rofina J; Tsangaris T; Gruys E
Amyloid; 2001 Mar; 8(1):11-21. PubMed ID: 11293821
[TBL] [Abstract][Full Text] [Related]
30. Reanalysis of the first case of Alzheimer's disease.
Graeber MB; Mehraein P
Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 3():10-3. PubMed ID: 10654094
[TBL] [Abstract][Full Text] [Related]
31. Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease.
Cummings BJ; Pike CJ; Shankle R; Cotman CW
Neurobiol Aging; 1996; 17(6):921-33. PubMed ID: 9363804
[TBL] [Abstract][Full Text] [Related]
32. The pathology of the neuronal cytoskeleton in Alzheimer's disease.
Brion JP
Biochim Biophys Acta; 1992 Nov; 1160(1):134-42. PubMed ID: 1384716
[TBL] [Abstract][Full Text] [Related]
33. [Expression of proteins related neurodegeneration in autopsy brains of the aged].
Zhu M; Meng X; Wang L; Hu Y; Zhang H; Han Z
Zhonghua Bing Li Xue Za Zhi; 2014 Oct; 43(10):651-6. PubMed ID: 25567589
[TBL] [Abstract][Full Text] [Related]
34. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.
Okamura N; Furumoto S; Fodero-Tavoletti MT; Mulligan RS; Harada R; Yates P; Pejoska S; Kudo Y; Masters CL; Yanai K; Rowe CC; Villemagne VL
Brain; 2014 Jun; 137(Pt 6):1762-71. PubMed ID: 24681664
[TBL] [Abstract][Full Text] [Related]
35. Alzheimer's disease plaques and tangles: cemeteries of a pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction.
Carter CJ
Neurochem Int; 2011 Feb; 58(3):301-20. PubMed ID: 21167244
[TBL] [Abstract][Full Text] [Related]
36. The search for diagnostic criteria in Alzheimer's disease: an update.
Prayson RA; Estes ML
Cleve Clin J Med; 1994; 61(2):115-22; quiz 162. PubMed ID: 8194175
[TBL] [Abstract][Full Text] [Related]
37. The neuropathological diagnosis of Alzheimer's disease: clinical-pathological studies.
Hyman BT
Neurobiol Aging; 1997; 18(4 Suppl):S27-32. PubMed ID: 9330982
[TBL] [Abstract][Full Text] [Related]
38. An autopsy case of Alzheimer's disease with a progressive supranuclear palsy overlap.
Urasaki K; Kuriki K; Namerikawa M; Satoh S; Ikeguchi K; Fukayama M; Saito K; Nakano I
Neuropathology; 2000 Sep; 20(3):233-8. PubMed ID: 11132941
[TBL] [Abstract][Full Text] [Related]
39. Is there a neuropathology difference between mild cognitive impairment and dementia?
Haroutunian V; Hoffman LB; Beeri MS
Dialogues Clin Neurosci; 2009; 11(2):171-9. PubMed ID: 19585952
[TBL] [Abstract][Full Text] [Related]
40. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease.
Dickson TC; Vickers JC
Neuroscience; 2001; 105(1):99-107. PubMed ID: 11483304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]